Rare diseases
Investigational molecules
Locations
200 Pine Street Suite 400, 94104-2704, United States
Napo Pharmaceuticals Inc. is focused on clinical research in Microvillous Inclusion Disease (MVID), a severe rare gastrointestinal disorder affecting intestinal function and fluid balance.
The sponsor’s current research interest centers on therapies intended to address the digestive and absorptive complications associated with MVID.
Napo Pharmaceuticals Inc. runs clinical trials in conditions such as Microvillous inclusion disease, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
ItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
